Dashboard
Manage Tickers

MRNAModerna, Inc.

Nasdaq modernatx.com


$ 117.30 $ -5.38 (-4.39 %)    

Friday, 10-May-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 117.31
$ 120.85
$ 0.00 x 0
$ 0.00 x 0
$ 116.86 - $ 124.76
$ 62.55 - $ 142.79
4,238,508
na
44.81B
$ 0.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stocks-pause-on-dismal-consumer-confidence-yields-dollar-rise-as-inflation-expectations-kick-higher-bitcoin-sinks-whats-driving-markets-friday-corrected
Stocks Pause On Dismal Consumer Confidence...
05/10/2024 17:28:26

Editor’s note: This story has been updated to correct an error in the price action of Charter Communications stock.

fda-delays-important-moderna-vaccine-review-william-blair-says-2025-growth-2026-breakeven-story-depends-on-it
FDA Delays 'Important' Moderna Vaccine Rev...
05/10/2024 13:27:05

FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.

moderna-says-that-fda-due-to-administrative-constraints-does-not-expect-to-complete-its-review-of-mrna-1345-respiratory-syncytial-virus-vaccine-by-may-12-the-fda-has-informed-moderna-that-it-is-working-to-conclude-the-review-by-the-end-of-may
Moderna Says That FDA, Due To Administrati...
05/10/2024 11:06:39

fda-has-has-informed-moderna-that-due-to-administrative-constraints-it-will-not-complete-its-review-of-mrna-1345-by-the-pdufa-date-of-may-12
FDA Has Has Informed Moderna That Due To A...
05/10/2024 11:05:05

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/09/2024 17:35:23

elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential
Elon Musk Breaks Ranks With GOP By Praisin...
05/09/2024 09:01:47

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

check-out-what-whales-are-doing-with-mrna
Check Out What Whales Are Doing With MRNA
05/07/2024 17:16:09

ubs-maintains-buy-on-moderna-raises-price-target-to-151
UBS Maintains Buy on Moderna, Raises Price...
05/07/2024 15:54:21

UBS analyst Eliana Merle maintains Moderna (NASDAQ:MRNA) with a Buy and raises the price target from $143 to $151.

modernas-options-frenzy-what-you-need-to-know
Moderna's Options Frenzy: What You Need to...
05/06/2024 14:31:05

which-large-cap-stocks-are-winning-this-earnings-season-15-stocks-to-watch-april-28-may-4-2024
Which Large-Cap Stocks Are Winning This Ea...
05/06/2024 00:48:12

Last week's top performers included Carvana, Pinterest, Moderna and JD.Com.

canaccord-genuity-maintains-hold-on-moderna-raises-price-target-to-106
Canaccord Genuity Maintains Hold on Modern...
05/03/2024 21:33:13

Canaccord Genuity analyst Bill Maughan maintains Moderna (NASDAQ:MRNA) with a Hold and raises the price target from $91 to $...

rbc-capital-maintains-outperform-on-moderna-raises-price-target-to-135
RBC Capital Maintains Outperform on Modern...
05/03/2024 16:59:03

RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Outperform and raises the price target from $125 to $135.

navigating-6-analyst-ratings-for-moderna
Navigating 6 Analyst Ratings For Moderna
05/03/2024 15:00:42

oppenheimer-maintains-outperform-on-moderna-raises-price-target-to-163
Oppenheimer Maintains Outperform on Modern...
05/03/2024 13:10:18

Oppenheimer analyst Hartaj Singh maintains Moderna (NASDAQ:MRNA) with a Outperform and raises the price target from $142 to ...

wall-street-inches-up-after-powells-inflation-remarks-chipmakers-rebound-gold-crude-falter-whats-driving-markets-thursday
Wall Street Inches Up After Powell's Infla...
05/02/2024 17:37:33

U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains.

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/02/2024 17:35:24

needham-reiterates-hold-on-moderna
Needham Reiterates Hold on Moderna
05/02/2024 17:18:32

Needham analyst Joseph Stringer reiterates Moderna (NASDAQ:MRNA) with a Hold.

moderna-reports-smaller-than-expected-q1-loss-prepares-for-rsv-vaccine-and-spikevax-2024-2025-formula-stock-soars
Moderna Reports Smaller Than Expected Q1 L...
05/02/2024 17:12:43

Moderna reports Q1 loss, beating sales estimates amidst declining COVID-19 vaccine demand. Cost-saving measures drive optimism ...

merck-reports-progress-on-the-cancer-front-as-it-prepares-for-keytruda-patent-expiration
Merck Reports Progress On The Cancer Front...
05/02/2024 16:53:54

After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just repo...

ch-robinson-worldwide-posts-upbeat-results-joins-avis-budget-group-qualcomm-borgwarner-moderna-and-other-big-stocks-moving-higher-on-thursday
C.H. Robinson Worldwide Posts Upbeat Resul...
05/02/2024 14:28:29

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION